multivessel

The SYNTAX Score II: a tool that should be used

Original title:&nbsp;Validation and Comparison of the Long-Term Prognostic Capability of SYNTAX Store-II Among 1528 Consecutive Patients Who Underwent Left Main Percutaneous Coronary Intervention.&nbsp;Reference:&nbsp;Bo Xu, et al. JACC Cardiovascular Intervention 2014;7:1128-37. &nbsp; The SYNTAX angiography score is useful when deciding revascularization in multivessel, but with the addition of clinical variables in the second version, SYNTAX score<a href="https://solaci.org/en/2014/12/03/n-4845/" title="Read more" >...</a>

FFR results could change over the years

Original title:&nbsp;The impact of age flow reserve-guided percutaneous coronary intervention: A FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) trial substudy.&nbsp;Reference:&nbsp;Hong-Seok Lim et al. International Journal of Cardiology 2014; 177:66-70 The FAME study has shown the benefit of FFR guided PCI, but the question as to whether age affects lesion evaluation remains unclear. A<a href="https://solaci.org/en/2014/11/17/n-4838/" title="Read more" >...</a>

Target amount for reasonable incomplete revascularization

Original title:&nbsp;Reasonable incomplete revascularisation after percutaneouscoronary intervention: the SYNTAX Revascularisation Index.&nbsp;Reference:&nbsp;Philippe G&eacute;n&eacute;reux et al. EuroIntervention 2014;10-online publish-ahead-of-print. While the absolute amount of residual disease after coronary angioplasty is associated with poor prognosis, the proportion of treated coronary disease modifying the prognosis is still to be determined. This study attempted to quantify the proportion of coronary<a href="https://solaci.org/en/2014/11/05/n-4810/" title="Read more" >...</a>

SYNTAX study final monitoring at 5-years

Original title:&nbsp;Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.&nbsp;Reference:&nbsp;Eur Heart J. 2014 May 21. pii: ehu213. (Epub ahead of print). The SYNTAX study was one of the largest randomized clinical studies comparing long-term results of angioplasty versus surgery in multivessel disease and /or<a href="https://solaci.org/en/2014/07/04/n-4579/" title="Read more" >...</a>

Hybrid revascularization versus conventional surgery. Advantages and disadvantages for choosing ideal patients.

Original title:&nbsp;Clinical Outcomes after Hybrid Coronary Revascularization versus Coronary Artery Bypass Surgery: A Meta-Analysis of 1,190 Patients.&nbsp;Reference:&nbsp;Ralf E. Harskamp et al. American Heart Journal (2014), epub ahead of print. &nbsp; Hybrid revascularization combines long-term patency of the mammary artery connected to the left anterior descending with minimally invasive drug-eluting stents to other injuries. This in<a href="https://solaci.org/en/2014/02/18/n-4271/" title="Read more" >...</a>

Culprit artery only versus revascularization with ST segment elevation myocardial infarction. The discussion continues

Original title:&nbsp;Complete Versus Culprit-Only Revascularization for Patients with Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.&nbsp;Reference:&nbsp;Kevin R et al. American Heart Journal, article in press. Primary angioplasty is the preferred reperfusion strategy in patients experiencing a STEMI as it has proven superior to fibrinolysis in reducing<a href="https://solaci.org/en/2013/11/06/n-4054/" title="Read more" >...</a>

Everolimus Eluting Stent in multiple vessels with short SYNTAX score

Original title:&nbsp;A Clinical and Angiographic Study of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With Multivessel Coronary Artery Disease. The EXECUTIVE (EXecutive RCT: Evaluating XIENCE V in a Multi Vessel Disease) Trial.&nbsp;Reference:&nbsp;Flavio Ribichini et al. J Am Coll Cardiol Intv 2013. Article in press. Drug-eluting stents (DES ) have emerged<a href="https://solaci.org/en/2013/09/24/n-3641/" title="Read more" >...</a>

Hybrid revascularization, combining strengths in high-risk patients

Original title:&nbsp;One-Stop Hybrid Coronary Revascularization versus Coronary Artery Bypass Graft and Percutaneous Coronary Intervention for the Treatment of Multivessel Coronary Artery Disease: Three-Year Follow-up Results from A Single Institution.&nbsp;Reference:&nbsp;Liuzhong Shen et al. J Am Coll Cardiol Intv 2013. Article in press. Accepted Manuscript. A mammary bridge to anterior descending artery (LMCA) with a permeability &gt;<a href="https://solaci.org/en/2013/05/03/n-2696/" title="Read more" >...</a>

Complete revascularization in one procedure is more cost effective and as safe as in stages.

Original title:&nbsp;Staged Versus One-time Complete Revascularization With Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease Patients Without ST-Elevation Myocardial Infarction.&nbsp;Reference:&nbsp;Edward L. Hannan et al. Circ Cardiovasc Interv 2013;6;12-20. There is evidence that in patients with multi-vessel disease affected by an acute coronary syndrome (ACS) with ST segment elevation, only the cause lesion should be treated<a href="https://solaci.org/en/2013/03/04/n-2934/" title="Read more" >...</a>

Complex angioplasty with ventricular assist

Original title:&nbsp;Real-Word of the Impella 2.5 Circulatory Support System in Complex High-Risk Percutaneous Coronary Intervention: The USpella Registry&nbsp;Reference:&nbsp;Brijeshwar maini, et al. Catheterization and Cardiovscular Intervention For about a decade angioplasty has begun to be performed in increasingly complex patients (PE) such as those with left coronary trunk injury, 3-vessel injury, poor ventricular function and surgically<a href="https://solaci.org/en/2012/11/29/n-3830/" title="Read more" >...</a>

Top